Predictiv

The DNA-based Digital Twin to predict and prevent risks on 16,000+ diseases
Analytics
Raised to Date: $84,223
Aggregate Commitments $
Republic
02/16/2021
04/30/2021
$25,000
$107,000
$100
SAFE
RegCF
Pre-Seed
$5,500,000
0%
Weekly Commitments $
Active
03/03/2021
57
337%
79%
$5,615
183
Mountain View, California
Healthcare & Pharmaceuticals
HealthTech
B2B2C
Medium
High
Predictiv, with a valuation cap of $5.5 million, is raising funds on Republic. The company has developed a comprehensive solution to measure the risk of about 16,000 diseases. The platform uses DNA next-generation sequencing to assess risk levels, sequence genes, analyze drugs, and simulate reactions to drugs. Sajung Yun and Sijung Yun founded Predictiv in July 2020. The current crowdfunding round has a minimum target of $25,000 and a maximum target of $107,000, and the proceeds will be used to improve the UI/UX, execute partnerships in the US and Asia, and expand the solution. Predictiv has filed two patents and expects to generate revenue of $70 million by 2024.
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$0 |
$0 |
COGS |
$0 |
$0 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-39,775 |
$0 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$13,605 |
$0 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$13,605 |
$0 |
Short-Term Debt |
$659 |
$0 |
Long-Term Debt |
$0 |
$0 |
Total Liabilities |
$659 |
$0 |
Other Deals

MedVector on StartEngine
The COVID-19 pandemic has grown the telehealth industry exponentially. A recent study of U.S medical specialists found that

Phoenix PharmaLabs on Netcapital
In the years before the world’s current COVID-19 crisis, America in particular faced a deadly and persistent threat…

C-Reveal Therapeutics on NetCapital
Cancer is the great, mysterious killer of medical science. As of January 2019, there were an